These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37022495)

  • 1. Endothelial dysfunction in children with newly diagnosed Graves' disease.
    Gamal Y; Badawy A; Ali AM; Farghaly HS; Metwalley KA; Gaber N; Allam MT; Farouk Y
    Eur J Pediatr; 2023 Jun; 182(6):2793-2800. PubMed ID: 37022495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Mediation Role of Thyrotropin Receptor Antibody in the Relationship Between Age and Severity of Hyperthyroidism in Graves' Disease.
    Suzuki N; Inoue K; Yoshimura R; Kinoshita A; Suzuki A; Fukushita M; Matsumoto M; Yoshihara A; Watanabe N; Noh JY; Katoh R; Sugino K; Ito K
    Thyroid; 2022 Oct; 32(10):1243-1248. PubMed ID: 36074931
    [No Abstract]   [Full Text] [Related]  

  • 3. The association of TSH-receptor antibody with the clinical and laboratory parameters in patients with newly diagnosed Graves' hyperthyroidism: experience from a tertiary referral center including a large number of patients with TSH-receptor antibody-negative patients with Graves' hyperthyroidism.
    Zuhur SS; Bilen O; Aggul H; Topcu B; Celikkol A; Elbuken G
    Endokrynol Pol; 2021; 72(1):14-21. PubMed ID: 32944926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction in Graves' disease.
    Popławska-Kita A; Szelachowska M; Modzelewska A; Siewko K; Dzięcioł J; Klimiuk PA; Górska M
    Adv Med Sci; 2013; 58(1):31-7. PubMed ID: 23612675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of an automated TSI bridge immunoassay in the diagnosis of Graves' disease and its relationship to the degree of hyperthyroidism.
    Liu T; Zhang X; Long L; Zhou L; Chen J; Li M; Gao Y; Zhou X; Han X; Ji L
    BMC Endocr Disord; 2022 Aug; 22(1):218. PubMed ID: 36045442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays.
    Pedersen IB; Knudsen N; Perrild H; Ovesen L; Laurberg P
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):381-90. PubMed ID: 11589682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular functions in children with newly diagnosed Graves' disease. A single-center study from Upper Egypt.
    Metwalley KA; Farghaly HS; Abdelhamid A
    Eur J Pediatr; 2018 Jan; 177(1):101-106. PubMed ID: 29103088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic testing for Graves' or non-Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography.
    Scappaticcio L; Trimboli P; Keller F; Imperiali M; Piccardo A; Giovanella L
    Clin Endocrinol (Oxf); 2020 Feb; 92(2):169-178. PubMed ID: 31742747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The serum concentration and activity of DPP4 is positively related with the severity of hyperthyroidism in patients with Graves' disease.
    Chang X; Ding X; Wang J; Cai Q; Wang G; Liu J
    Ann Med; 2023 Dec; 55(1):2226910. PubMed ID: 37350750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of thyroglobulin antibodies and thyroid peroxidase antibodies in Graves' disease: a cross-sectional study.
    Katahira M; Tsunekawa T; Mizoguchi A; Yamaguchi M; Tsuru K; Takashima H; Terada R
    Hormones (Athens); 2023 Jun; 22(2):253-261. PubMed ID: 36811756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble CD40 Ligand Levels in Children with Newly Diagnosed Graves’ Disease.
    Metwalley KA; Farghaly HS; Raafat DM; Ismail AM; Saied GM
    J Clin Res Pediatr Endocrinol; 2020 Jun; 12(2):197-201. PubMed ID: 31782290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased serum level of IL-7 in patients with active Graves' disease.
    Motylewska E; Nieć M; Siejka A; Komorowski J; Ławnicka H; Świętosławski J; Stępień H
    Cytokine; 2015 Oct; 75(2):373-9. PubMed ID: 26113403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-Up of Thyroid Function in Children With Neonatal Hyperthyroidism.
    Pyrżak B; Rumińska M; Witkowska-Sędek E; Kucharska A
    Front Endocrinol (Lausanne); 2022; 13():877119. PubMed ID: 35600602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivated SARS-CoV-2 vaccination does not disturb the clinical course of Graves' disease: An observational cohort study.
    Xu S; Yu H; Cheng X; Wu J; Bao J; Zhang L
    Vaccine; 2023 Aug; 41(38):5648-5654. PubMed ID: 37544826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperthyroidism during pregnancy--the role of measuring maternal TSH receptor antibodies and foetal ultrasound monitoring.
    Gietka-Czernel M; Dębska M; Kretowicz P; Zgliczyński W; Ołtarzewski M
    Endokrynol Pol; 2014; 65(4):259-68. PubMed ID: 25185847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
    Kumeda Y; Inaba M; Tahara H; Kurioka Y; Ishikawa T; Morii H; Nishizawa Y
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF1 deficiency in newly diagnosed Graves' disease patients.
    Martin S; Sirbu A; Betivoiu M; Florea S; Barbu C; Fica S
    Hormones (Athens); 2015; 14(4):651-9. PubMed ID: 26188228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of thyrotropin (TSH) receptor antibodies in children and adolescents with Graves' disease treated using antithyroid medication.
    Smith J; Brown RS
    Thyroid; 2007 Nov; 17(11):1103-7. PubMed ID: 17822376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased serum interleukin-41/Metrnl levels in patients with Graves' disease.
    Gong L; Huang G; Weng L; Xu J; Li Y; Cui W; Li M
    J Clin Lab Anal; 2022 Oct; 36(10):e24676. PubMed ID: 36036749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.